Vitamine D et sclérose en plaques. Étude prospective d’une cohorte de patients de la région Poitou-Charentes

Almirall, 2010, Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly, Nephrol Dial Transplant, 25, 503, 10.1093/ndt/gfp470 Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part I: the role of infection, Ann Neurol, 61, 288, 10.1002/ana.21117 Ascherio, 2007, Environmental risk factors for multiple sclerosis. Part II: noninfectious factors, Ann Neurol, 61, 504, 10.1002/ana.21141 Ascherio, 2010, Vitamin D and multiple sclerosis, Lancet Neurol, 9, 599, 10.1016/S1474-4422(10)70086-7 Barnes, 2007, Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers, Mult Scler, 13, 670, 10.1177/1352458506072666 Barnett CM, Nielson CM, Shannon J, Chan JM, Shikany JM, Bauer DC, et al. Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control. 2010;21:1297–1303. Becklund, 2010, UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production, Proc Natl Acad Sci U S A, 107, 6418, 10.1073/pnas.1001119107 Beretich, 2009, Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis, Mult Scler, 15, 891, 10.1177/1352458509105579 Bischoff-Ferrari, 2006, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am J Clin Nutr, 84, 18, 10.1093/ajcn/84.1.18 Burton, 2010, A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis, Neurology, 74, 1852, 10.1212/WNL.0b013e3181e1cec2 Chapuy, 1996, Prevalence of vitamin D insufficiency in an adult normal population, Osteoporosis Int, 7, 439, 10.1007/s001980050030 Correale, 2009, Immunomodulatory aspects of vitamin D in multiple sclerosis, Brain, 132, 1146, 10.1093/brain/awp033 Fardellone, 1991, Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, 58, 99 Fromont, 2009, Épidémiologie de la sclérose en plaques : la particularité française, Rev Neurol (Paris), 165, 671, 10.1016/j.neurol.2009.04.003 Fromont, 2010, Geographic variations of multiple sclerosis in France, Brain, 133, 1889, 10.1093/brain/awq134 Goldberg, 1986, Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D, Med Hypotheses, 21, 193, 10.1016/0306-9877(86)90010-1 Gouni-Berthold, 2009, Vitamin D and cardiovascular disease, Curr Vasc Pharmacol, 7, 414, 10.2174/157016109788340686 Hanwell, 2009, Vitamin D status as a predictor of multiple sclerosis outcome following an initial pediatric demyelinating event, Mult Scler, 15, S40 Harpavat, 2004, Metabolic bone disease in inflammatory bowel disease, J Clin Gastroenterol, 38, 218, 10.1097/00004836-200403000-00005 Hiremath, 2009, Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis, Mult Scler, 15, 735, 10.1177/1352458509102844 Holick, 2005, The Vitamin D epidemic and its health consequences, J Nutr, 135, 2739S, 10.1093/jn/135.11.2739S Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Holmøy, 2009, 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis, Mult Scler, 15, 1280, 10.1177/1352458509107008 Hughes, 2009, Vitamin D and respiratory health, Clin Exp Immunol, 158, 20, 10.1111/j.1365-2249.2009.04001.x Hyppönen, 2007, Hypovitaminosis D in British adults at age 45 yrs: nationwide cohort study of dietary and lifestyle predictors, Am J Clin Nutr, 85, 860, 10.1093/ajcn/85.3.860 Kampman, 2007, Outdoor activities and diet in childhood and adolescence relate to MS risk above the Artic Circle, J Neurol, 254, 471, 10.1007/s00415-006-0395-5 Kampman, 2008, Vitamin D: a candidate for the environmental effect in multiple sclerosis–observations from Norway, Neuroepidemiology, 30, 140, 10.1159/000122330 Kanazawa, 2010, Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis, Am J Med Sci, 339, 519, 10.1097/MAJ.0b013e3181db6dfe Kayaniyil, 2010, Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes, Diabetes Care, 33, 1379, 10.2337/dc09-2321 Kimball, 2007, Safety of vitamin D3 in adults with multiple sclerosis, Am J Clin Nutr, 86, 645, 10.1093/ajcn/86.3.645 Kragt, 2008, Higher levels of 25-hydryvitamin D are associated with a lower incidence of multiple sclerosis only in women, Mult Scler, 14, 1 Leventis, 2008, Clinical aspects of vitamin D in the management of rheumatoid arthritis, Rheumatology (Oxford), 47, 1617, 10.1093/rheumatology/ken296 McDowell, 2010, Time of birth, residential solar radiation and age at onset of multiple sclerosis, Neuroepidemiology, 34, 238, 10.1159/000297749 Mehan, 2002, The vitamin D receptor is essential for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice, Arch Biochem Biophys, 408, 200, 10.1016/S0003-9861(02)00580-5 Mehta, 2010, New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence, J Neurol Sci, 292, 5, 10.1016/j.jns.2010.02.004 Mehta, 2010, Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality, PLoS One, 5, e8770, 10.1371/journal.pone.0008770 Mowry, 2010, Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis, Ann Neurol, 67, 618 Munger, 2004, Vitamin D intake and incidence of multiple sclerosis, Neurology, 62, 60, 10.1212/01.WNL.0000101723.79681.38 Munger, 2006, Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis, JAMA, 296, 2832, 10.1001/jama.296.23.2832 Myhr, 2009, Vitamin D treatment in multiple sclerosis, J Neurol Sci, 286, 104, 10.1016/j.jns.2009.05.002 Noonan, 2010, The prevalence of multiple sclerosis in 3 US communities, Prev Chronic Dis, 7, A12 Pierrot-Deseilligny, 2009, Clinical implications of a possible role of vitamin D in multiple sclerosis, J Neurol, 256, 1468, 10.1007/s00415-009-5139-x Pierrot-Deseilligny, 2010, Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?, Brain, 133, 1869, 10.1093/brain/awq147 Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Ann Neurol, 58, 840, 10.1002/ana.20703 Simpson, 2010, Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis, Ann Neurol, 68, 193 Sloka, 2008, The relation of ultraviolet radiation and multiple sclerosis in Newfoundland, Can J Neurol Sci, 35, 69, 10.1017/S0317167100007587 Smolders, 2008, Vitamin D as an immune modulator in multiple sclerosis, a review, J Neuroimmunol, 194, 7, 10.1016/j.jneuroim.2007.11.014 Smolders, 2008, Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis, Mult Scler, 14, 1, 10.1177/1352458508094399 Soilu-Hänninen, 2005, 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis, Mult Scler, 11, 266, 10.1191/1352458505ms1157oa Soilu-Hänninen, 2008, A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis, J Neurol Neurosurg Psychiatry, 79, 152, 10.1136/jnnp.2006.105320 Spach, 2005, Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice, J Immunol, 175, 4119, 10.4049/jimmunol.175.6.4119 Steffensen, 2010, Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis, J Neurol, 257, 410, 10.1007/s00415-009-5337-6 Stolzenberg-Solomon, 2010, Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers, Am J Epidemiol, 172, 81, 10.1093/aje/kwq120 Urashima, 2010, Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Am J Clin Nutr, 91, 1255, 10.3945/ajcn.2009.29094 Van der Mei, 2001, Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation, Neuroepidemiology, 20, 168, 10.1159/000054783 Van der Mei, 2007, Vitamin D levels in people with multiple sclerosis and community controls in Tasmania Australia, J Neurol, 254, 581, 10.1007/s00415-006-0315-8 Van der Mei, 2007, The high prevalence of vitamin D insufficiency across Australian population is only partly explained by season and latitude, Environ Health Perspect, 115, 1132, 10.1289/ehp.9937 Vukusik, 2007, Regional variations of multiple sclerosis prevalence in French farmers, J Neurol Neurosurg Psychiatry, 78, 707, 10.1136/jnnp.2006.101196 Wingerchuk, 2005, A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis, J Neurol Neurosurg Psychiatry, 76, 1294, 10.1136/jnnp.2004.056499 Wingerchuk, 2010, Supplementing our understanding of vitamin D and multiple sclerosis, Neurology, 74, 1846, 10.1212/WNL.0b013e3181e3d96c